Latest news with #BioLabs
Zawya
6 days ago
- Health
- Zawya
Saudi Arabia launches first biotech accelerator program at BIO 2025 in Boston
BOSTON – Saudi Arabia's Ministry of Health has unveiled its first national biotech accelerator program at the BIO International Convention 2025 in Boston, marking a major step in the Kingdom's efforts to drive innovation and foster global collaboration in the life sciences sector. Developed in partnership with US-based BioLabs, the program aims to support emerging Saudi biotech startups by providing access to advanced laboratories, expert mentorship, and international research networks. The initiative is the first BioLabs collaboration in the Middle East and will run over a seven-month period, offering structured tracks to help startups scale and commercialize cutting-edge solutions. The program aligns with Saudi Arabia's Vision 2030 and the National Biotechnology Strategy, which seek to position the Kingdom as a regional leader in biotech innovation, enhance health outcomes, and diversify the economy through knowledge-based sectors. By launching the accelerator at one of the world's most influential biotech gatherings, Saudi Arabia is signaling its commitment to becoming a hub for biotechnology research, talent development, and investment. The initiative also supports the broader Health Sector Transformation Program, which is focused on modernizing healthcare services and promoting the development of high-impact technologies across the Kingdom.
Leaders
20-06-2025
- Health
- Leaders
Health Ministry Unveils 'Biotech Accelerator' to Drive Innovation at BIO 2025
Vice Minister of Health for Planning and Development, Abdulaziz Al-Rumaih, announced at the 2025 BIO International Convention in Boston, USA, the launch of the Ministry of Health's new 'Biotech Accelerator' program for biotechnology startups. This initiative, developed in partnership with BioLabs, is designed to stimulate innovation, enhance international collaboration, and empower Saudi biotech companies to elevate healthcare services. This pioneering program—the first of its kind in the Kingdom and the first BioLabs partnership in the Middle East—supports the objectives of both the Health Sector Transformation Program and the National Biotechnology Strategy, key pillars of Saudi Vision 2030. These initiatives seek to cultivate a thriving society and dynamic economy while positioning Saudi Arabia as a global leader in health innovation. Running over seven months, the Biotech Accelerator will provide startups with comprehensive training, structured support tracks, and access to cutting-edge research laboratories. Related Topics : SFDA Boosts Cooperation with European Institute of Innovation and Technology Health Minister Inspects Arafat Field Hospital Ahead of Hajj Rituals Stride into Health: Saudi Launches 'Walk 30' Public Fitness Drive Makkah Municipality Issues Health Certificate Guidelines for Hajj Season 1446 Short link : Post Views: 5 Related Stories
Boston Globe
03-04-2025
- Business
- Boston Globe
At life sciences incubator LabCentral, a change at the top in a challenging time
'We have really changed the way that people build biotech companies,' said Fruehauf, 55, who designed LabCentral as a way for cash-starved startups to save time and money by sharing infrastructure and lab equipment. 'We proposed a new model that seemed crazy and outrageous at the time and it's now being copied all over.' Fruehauf said he's stepping away from day-to-day management to spend more time on the global expansion of his two other businesses, for-profit BioLabs and Mission BioCapital, a venture capital firm. Advertisement The change at the top comes as LabCentral, which has nurtured the growth of 278 life sciences companies over the past decade, O'Toole, 56, who worked at about a dozen startups before joining LabCentral, has been deeply involved in its operations and growth since its founding. She's been responsible for space design, operations at six facilities, and community programming where entrepreneurs and researchers can network, swap tips, and share best practices. Advertisement A major goal in her new role, she said, is to help address 'pain points' for member companies at a time of transition in the life sciences sector. Among other steps, she's working to match them up with investors, including many of the drug giants that are LabCentral sponsors. Just last month, one of LabCentral's member companies, MIT-founded Gensaic, which uses AI-powered protein design to improve the tissue targeting of therapies, O'Toole said she's also been talking with others in the sector about finding ways to offset the impacts of 'I want to think of creative ways that we can offset these challenges and not have innovation be limited as a result of the funding gap,' said LabCentral's incoming CEO Maggie O'Toole. Lane Turner/Globe Staff 'In light of some of the challenges going on in the industry,' O'Toole said, 'I really want to find the right way for us to support our companies. ... I want to think of creative ways that we can offset these challenges and not have innovation be limited as a result of the funding gap.' Fruehauf, who immigrated from Germany, said he's also concerned about whether the United States will continue to be the engine for scientific breakthroughs that has drawn scientists from around the globe. 'The basic science machine that's been going on very successfully over many decades has been put in jeopardy,' he said. 'We hope and we believe that it will become evident to the decision makers that it is in our common interest to not undermine this area where American leads. ... The innovation enterprise in this country is the envy of the world.' Advertisement Maggie O'Toole, incoming CEO, and Johannes Fruehauf, outgoing CEO, in Kendall Square space of LabCentral, which now owns or manages a half dozen biotech coworking spaces spanning 243,000 square feet in Cambridge and Boston. Lane Turner/Globe Staff LabCentral has expanded from its initial site at 700 Main St. in Kendall Square, built with the help of two grants totaling $10 million from the Massachusetts Life Sciences Center. It now owns or manages a half dozen biotech coworking spaces spanning 243,000 square feet in Cambridge and Boston. They include a pair of lab incubators it manages for Harvard in Allston and the Longwood Medical Area in Boston. More recently, however, occupancy rates are down at LabCentral and across Kendall Square and other Massachusetts biotech clusters. LabCentral abandoned plans for more sites even as it announced it was opening a new O'Toole said she doesn't foresee a major shakeup at LabCentral but wants to improve its 'concierge level of service' to the startups that work there until they advance to the stage where they need larger spaces. Even as she's managed LabCentral operations, O'Toole, a former college swimmer who competes in triathlons, has been an evangelist for the LabCentral model around the world, visiting with life sciences innovators in far-flung locales from Korea and China to Sweden and Australia. She's also hosted hundreds of delegations from across the country and overseas that have visited LabCentral on trips to Cambridge over the years. Just last week, she met with 20 visitors from Oslo, Norway. 'They were trying to understand the secret of Kendall Square,' she said. Robert Weisman can be reached at
